pamidronate has been researched along with Cystic Fibrosis in 7 studies
Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intravenous pamidronate increases axial BMD in adults with cystic fibrosis, but the high incidence of bone pain associated with this treatment might limit its use." | 9.09 | Effect of intravenous pamidronate on bone mineral density in adults with cystic fibrosis. ( Adams, JE; Haworth, CS; Horrocks, AW; Mawer, EB; Selby, PL; Webb, AK, 2001) |
| "Intravenous pamidronate increases axial BMD in adults with cystic fibrosis, but the high incidence of bone pain associated with this treatment might limit its use." | 5.09 | Effect of intravenous pamidronate on bone mineral density in adults with cystic fibrosis. ( Adams, JE; Haworth, CS; Horrocks, AW; Mawer, EB; Selby, PL; Webb, AK, 2001) |
| "Osteoporosis is a disorder of bone mineralisation occurring in about one third of adults with cystic fibrosis." | 3.01 | Bisphosphonates for osteoporosis in people with cystic fibrosis. ( Chang, AB; Conwell, LS; Jeffery, TC, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Jeffery, TC | 1 |
| Chang, AB | 1 |
| Conwell, LS | 1 |
| Haworth, CS | 3 |
| Selby, PL | 3 |
| Webb, AK | 3 |
| Mawer, EB | 2 |
| Adams, JE | 3 |
| Freemont, TJ | 2 |
| Teramoto, S | 1 |
| Matsuse, T | 1 |
| Ouchi, Y | 1 |
| Aris, RM | 1 |
| Lester, GE | 1 |
| Renner, JB | 1 |
| Winders, A | 1 |
| Denene Blackwood, A | 1 |
| Lark, RK | 1 |
| Ontjes, DA | 1 |
| Horrocks, AW | 1 |
| Garske, LA | 1 |
| Bell, SC | 1 |
1 review available for pamidronate and Cystic Fibrosis
| Article | Year |
|---|---|
Bisphosphonates for osteoporosis in people with cystic fibrosis.
Topics: Adult; Alendronate; Bone Density Conservation Agents; Child; Cystic Fibrosis; Diphosphonates; Female | 2023 |
3 trials available for pamidronate and Cystic Fibrosis
| Article | Year |
|---|---|
Severe bone pain after intravenous pamidronate in adult patients with cystic fibrosis.
Topics: Adult; Anti-Inflammatory Agents; Bone Density; Bone Diseases; Cystic Fibrosis; Diphosphonates; Dose- | 1998 |
Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Bone Density; Cystic Fibrosis; Diphosphonates; Drug Adm | 2000 |
Effect of intravenous pamidronate on bone mineral density in adults with cystic fibrosis.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Bone Density; Bone Diseases, Metabolic; Calcium; Cystic | 2001 |
3 other studies available for pamidronate and Cystic Fibrosis
| Article | Year |
|---|---|
Increased cytokines and pamidronate-induced bone pain in adults with cystic fibrosis.
Topics: Adult; Anti-Inflammatory Agents; Bone Diseases; Cystic Fibrosis; Diphosphonates; Humans; Pain; Pamid | 1999 |
Oral corticosteroids and bone pain after pamidronate in adults with cystic fibrosis.
Topics: Adult; Anti-Infective Agents; Bone Diseases; Cystic Fibrosis; Diphosphonates; Glucocorticoids; Human | 1999 |
Pamidronate results in symptom control of hypertrophic pulmonary osteoarthropathy in cystic fibrosis.
Topics: Adult; Ankle; Cystic Fibrosis; Diphosphonates; Female; Humans; Infusions, Intravenous; Osteoarthropa | 2002 |